This 2008 multicenter cohort study (Anticancer Research, PMID: 18383896) evaluated the impact of standardized mistletoe extract (HELIXOR) as a complementary therapy in the aftercare of 681 breast cancer patients across 53 hospitals and practices in Germany. Among them, 167 received mistletoe extract, while 514 served as controls. Over approximately five
